Research Article
[Retracted] Fetal Congenital Cardiac and Vascular Disorders Associated with Sertraline Treatment during Pregnancy: Analysis of FAERS Data
Table 4
Clinical indication of sertraline.
| Characteristics | Reports, no. (%) |
| Indication | 689 | Depression (10012378) | 355 | (51.52%) | Anxiety (10002855) | 136 | (19.74%) | Affective disorder (10001443) | 71 | (10.3%) | Product used for unknown indication (10070592) | 24 | (3.48%) | Perinatal depression (10078366) | 15 | (2.18%) | Ill-defined disorder (10061520) | 11 | (1.6%) | Panic disorder (10033666) | 10 | (1.45%) | Prophylaxis of neural tube defect (10054930) | 7 | (1.02%) | Adrenal disorder (10001347) | 6 | (0.87%) | Anxiety disorder (10057666) | 6 | (0.87%) | Morning sickness (10027975) | 6 | (0.87%) | Depressive symptom (10054089) | 5 | (0.73%) | Obsessive-compulsive disorder (10029898) | 5 | (0.73%) | Prophylaxis (10036898) | 4 | (0.58%) | Bacterial test positive (10059421) | 3 | (0.44%) | Generalised anxiety disorder (10018075) | 3 | (0.44%) | Major depression (10057840) | 3 | (0.44%) | Posttraumatic stress disorder (10036316) | 3 | (0.44%) | Psychiatric symptom (10061472) | 3 | (0.44%) | Bronchitis (10006451) | 2 | (0.29%) | Maternal drugs affecting fetus (10026923) | 2 | (0.29%) | Panic attack (10033664) | 2 | (0.29%) | Antidepressant therapy (10054976) | 1 | (0.15%) | Depressed mood (10012374) | 1 | (0.15%) | Disability (10013050) | 1 | (0.15%) | Maternal exposure timing unspecified (10071415) | 1 | (0.15%) | Mood swings (10027951) | 1 | (0.15%) | Nervous system disorder (10029202) | 1 | (0.15%) |
|
|